SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437786-17-000025
Filing Date
2017-05-17
Accepted
2017-05-17 16:56:32
Documents
5
Period of Report
2017-05-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K immuneform8k1q17.htm 8-K 35140
2 EXHIBIT 99.1 exhibit991earnings1q17.htm EX-99.1 70150
3 EXHIBIT 99.2 exhibit992asco.htm EX-99.2 30008
4 image0a04.gif GRAPHIC 15642
5 image0a05.gif GRAPHIC 15642
  Complete submission text file 0001437786-17-000025.txt   179884
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36561 | Film No.: 17852258
SIC: 2834 Pharmaceutical Preparations